Blackmores (ASX:BKL) $159.40 as at 28/08/2018
This morning Blackmores (ASX:BKL) reported their full year results and they were above market expectations, with revenue rebounding strongly from FY17 to FY18 (up 9%) and NPAT increasing by 19%. It’s been a volatile few years for the vitamin maker however it seems management have now re-aligned the business, optimised the cost structure and are now pushing hard into Asia.
The composition of the result was interesting, with Q4 revenue a strong point while they also had the added benefit of expanding margins.
Blackmores (BKL) Chart
Market Matters Take/Outlook
The market focused on revenue growth for BKL which has been the norm for these growth orientated stocks this reporting season. Q4 momentum seems strong in the business and this bodes well for FY19. View more consumer staple reports here.